Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Amitriptyline hydrochloride; perphenazine - Generic Drug Details

« Back to Dashboard

What are the generic sources for amitriptyline hydrochloride; perphenazine and what is the scope of amitriptyline hydrochloride; perphenazine patent protection?

Amitriptyline hydrochloride; perphenazine
is the generic ingredient in ten branded drugs marketed by Watson Labs, Schering, New River, Par Pharm, Ivax Sub Teva Pharms, Mylan, Sandoz, and Sun Pharm Inds, and is included in thirty-seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for amitriptyline hydrochloride; perphenazine. One supplier is listed for this compound.

Summary for Generic Name: amitriptyline hydrochloride; perphenazine

Drug Master File Entries: see list13
Suppliers / Packagers: see list1
Clinical Trials: see list1,020
Drug Prices:see low prices
DailyMed Link:amitriptyline hydrochloride; perphenazine at DailyMed

Pharmacology for Ingredient: amitriptyline hydrochloride; perphenazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
New River
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014713-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
amitriptyline hydrochloride; perphenazine
TABLET;ORAL071443-005Nov 10, 1988RXNoYes► Subscribe► Subscribe
Watson Labs
amitriptyline hydrochloride; perphenazine
TABLET;ORAL070373-001Aug 25, 1986DISCNNoNo► Subscribe► Subscribe
Watson Labs
amitriptyline hydrochloride; perphenazine
TABLET;ORAL070377-001Nov 4, 1986DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus